PEAQX: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''PEAQX''' is a competitive antagonist of the [[NMDA receptor]], a type of ionotropic glutamate receptor in the brain. It is used in scientific research to help understand the function of NMDA receptors, and has potential therapeutic applications in conditions such as [[stroke]], [[epilepsy]], and [[neurodegenerative diseases]].
{{DISPLAYTITLE:PEAQX}}
 
== Overview ==
'''PEAQX''' is a chemical compound known for its role as a selective antagonist of the [[AMPA receptor]], a type of [[ionotropic glutamate receptor]] in the [[central nervous system]]. It is primarily used in [[neuroscience]] research to study the function of AMPA receptors and their involvement in [[synaptic transmission]] and [[plasticity]].
 
== Chemical Structure ==
[[File:PEAQX.svg|thumb|right|Chemical structure of PEAQX]]
PEAQX is a synthetic compound with a complex chemical structure that allows it to selectively bind to AMPA receptors. Its molecular formula is C18H18N4O4, and it is characterized by its ability to inhibit the activity of these receptors without affecting other types of glutamate receptors, such as [[NMDA receptors]].


== Mechanism of Action ==
== Mechanism of Action ==
PEAQX acts by binding to the glutamate site of the NMDA receptor, preventing the activation of the receptor by glutamate. This inhibits the flow of ions through the receptor, reducing the excitatory synaptic transmission in the brain.
PEAQX functions by binding to the AMPA receptor at the [[glutamate]] binding site, preventing the receptor from being activated by its natural ligand. This inhibition blocks the flow of [[sodium]] and [[calcium]] ions through the receptor channel, thereby modulating [[excitatory synaptic transmission]] in the brain. This property makes PEAQX a valuable tool in the study of [[neurophysiology]] and [[neuropharmacology]].
 
== Uses ==
PEAQX is primarily used in scientific research to study the function of NMDA receptors. It has been used in experiments to investigate the role of these receptors in learning and memory, pain perception, and neurodegeneration.


In addition to its research uses, PEAQX has potential therapeutic applications. It may be useful in the treatment of conditions that are associated with excessive activation of NMDA receptors, such as stroke, epilepsy, and neurodegenerative diseases.
== Applications in Research ==
PEAQX is widely used in laboratory settings to investigate the role of AMPA receptors in various neurological processes. It is particularly useful in studies of [[long-term potentiation]] (LTP) and [[long-term depression]] (LTD), which are cellular mechanisms underlying [[learning]] and [[memory]]. By selectively blocking AMPA receptors, researchers can better understand their contribution to these processes and explore potential therapeutic targets for [[neurological disorders]].


== Side Effects ==
== Safety and Handling ==
As with any drug, PEAQX can have side effects. These can include nausea, dizziness, and headaches. However, these side effects are generally mild and temporary.
As with many research chemicals, PEAQX should be handled with care. It is important to follow appropriate safety protocols, including the use of [[personal protective equipment]] (PPE) and working in a well-ventilated area. Researchers should consult the material safety data sheet (MSDS) for detailed information on handling and potential hazards.


== See Also ==
== Related Pages ==
* [[NMDA receptor antagonist]]
* [[AMPA receptor]]
* [[Glutamate receptor]]
* [[Glutamate receptor]]
* [[Neurodegeneration]]
* [[Synaptic transmission]]
 
* [[Neuropharmacology]]
== References ==
* [[Long-term potentiation]]
<references />


[[Category:Drugs]]
[[Category:Neuroscience]]
[[Category:Neuroscience]]
[[Category:Pharmacology]]
[[Category:Pharmacology]]
{{stub}}
[[Category:Chemical compounds]]

Latest revision as of 03:26, 13 February 2025


Overview[edit]

PEAQX is a chemical compound known for its role as a selective antagonist of the AMPA receptor, a type of ionotropic glutamate receptor in the central nervous system. It is primarily used in neuroscience research to study the function of AMPA receptors and their involvement in synaptic transmission and plasticity.

Chemical Structure[edit]

Chemical structure of PEAQX

PEAQX is a synthetic compound with a complex chemical structure that allows it to selectively bind to AMPA receptors. Its molecular formula is C18H18N4O4, and it is characterized by its ability to inhibit the activity of these receptors without affecting other types of glutamate receptors, such as NMDA receptors.

Mechanism of Action[edit]

PEAQX functions by binding to the AMPA receptor at the glutamate binding site, preventing the receptor from being activated by its natural ligand. This inhibition blocks the flow of sodium and calcium ions through the receptor channel, thereby modulating excitatory synaptic transmission in the brain. This property makes PEAQX a valuable tool in the study of neurophysiology and neuropharmacology.

Applications in Research[edit]

PEAQX is widely used in laboratory settings to investigate the role of AMPA receptors in various neurological processes. It is particularly useful in studies of long-term potentiation (LTP) and long-term depression (LTD), which are cellular mechanisms underlying learning and memory. By selectively blocking AMPA receptors, researchers can better understand their contribution to these processes and explore potential therapeutic targets for neurological disorders.

Safety and Handling[edit]

As with many research chemicals, PEAQX should be handled with care. It is important to follow appropriate safety protocols, including the use of personal protective equipment (PPE) and working in a well-ventilated area. Researchers should consult the material safety data sheet (MSDS) for detailed information on handling and potential hazards.

Related Pages[edit]